HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erik Bloomquist Selected Research

Chronic-Phase Myeloid Leukemia (Leukemia, Myeloid, Chronic Phase)

1/2019U.S. Food and Drug Administration Benefit-Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erik Bloomquist Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
10/2022 - 11/2015
5Fatigue
01/2020 - 11/2015
5Neutropenia
01/2020 - 11/2015
4Disease Progression
01/2021 - 11/2015
4Diarrhea
01/2020 - 11/2015
4Nausea
01/2020 - 10/2016
3Neoplasms (Cancer)
01/2021 - 11/2015
3Headache (Headaches)
01/2020 - 10/2016
3Leukopenia
01/2018 - 11/2015
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2021
2Constipation
01/2020 - 01/2018
2Alopecia (Baldness)
01/2020 - 01/2018
2Anemia
01/2020 - 10/2016
2Peripheral Nervous System Diseases (PNS Diseases)
01/2020 - 01/2020
2Thrombocytopenia (Thrombopenia)
01/2020 - 10/2016
2Vomiting
01/2020 - 01/2018
1Ovarian Epithelial Carcinoma
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Hemorrhage
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Triple Negative Breast Neoplasms
01/2020
1Arthralgia (Joint Pain)
01/2020
1Primary Headache Disorders
01/2020
1Musculoskeletal Pain
01/2020
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019
1Chronic-Phase Myeloid Leukemia (Leukemia, Myeloid, Chronic Phase)
01/2019
1Leukemia
01/2019
1Back Pain (Backache)
01/2018
1Infections
10/2016
1Stomatitis
10/2016
1Hypertension (High Blood Pressure)
11/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2015
1Febrile Neutropenia
11/2015
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2015

Drug/Important Bio-Agent (IBA)

7Hormones (Hormone)IBA
10/2022 - 10/2016
3ErbB Receptors (EGF Receptor)IBA
10/2022 - 11/2015
3Fulvestrant (Faslodex)FDA Link
11/2021 - 10/2016
3Cyclin-Dependent Kinase 4IBA
11/2021 - 01/2018
3palbociclibIBA
01/2020 - 11/2015
3Aromatase InhibitorsIBA
01/2020 - 01/2018
3Pharmaceutical PreparationsIBA
01/2020 - 06/2015
3Letrozole (Femara)FDA LinkGeneric
01/2020 - 11/2015
2PlatinumIBA
01/2021 - 11/2015
2taxaneIBA
01/2021 - 01/2020
2Estrogen ReceptorsIBA
01/2020 - 11/2015
1abemaciclibIBA
10/2022
1Bevacizumab (Avastin)FDA Link
01/2021
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1olaparibIBA
01/2021
1rucaparibIBA
01/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021
1Transaminases (Aminotransferases)IBA
01/2020
1Ado-Trastuzumab EmtansineIBA
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1Albumin-Bound PaclitaxelFDA Link
01/2020
1Progesterone Receptors (Progesterone Receptor)IBA
01/2020
1atezolizumabIBA
01/2020
1nilotinibFDA Link
01/2019
1ribociclibIBA
01/2018
1Docetaxel (Taxotere)FDA Link
11/2015
1Monoclonal AntibodiesIBA
11/2015
1Anaplastic Lymphoma KinaseIBA
11/2015
1RamucirumabIBA
11/2015
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2015
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2015
1belinostatIBA
06/2015
1Histone Deacetylase InhibitorsIBA
06/2015

Therapy/Procedure

9Therapeutics
10/2022 - 11/2015
3Drug Therapy (Chemotherapy)
01/2021 - 11/2015
1Cytoreduction Surgical Procedures
01/2021